Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 48, 2018 - Issue 1
670
Views
20
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Comparative pharmacokinetics between madecassoside and asiaticoside presented in a standardised extract of Centella asiatica, ECa 233 and their respective pure compound given separately in rats

, , , &
Pages 18-27 | Received 20 Oct 2016, Accepted 13 Dec 2016, Published online: 18 Jan 2017
 

Abstract

1. ECa 233, the standardised extract of Centella asiatica, contains not less than 80% triterpenoid glycosides, in a madecassoside:asiaticoside ratio of 1.5 (±0.5):1.

2. The pharmacokinetic comparison of madecassoside and asiaticoside was performed in rats following intravenous and oral administration of ECa 233, or an equivalent dose of the individual compounds. Blood, tissues, urine and faeces were collected after dosing to determine drug and metabolite levels using liquid chromatography–tandem mass spectrometry.

3. Our study demonstrated that plasma levels of madecassoside, and to a lesser extent asiaticoside, were higher after administration of ECa 233 than the corresponding values for the pure compounds. There was a bidirectional interconversion between asiaticoside and madecassoside consistent with the increased exposure of madecassoside and asiaticoside in ECa 233.

4. Both madecassoside and asiaticoside appeared to be widely distributed in several organs and metabolized extensively; following intravenous administration of either compound, approximately 80–90% of the dose was recovered as madecassic acid and asiatic acid in the faeces.

Acknowledgements

The authors are deeply grateful to Dr. Thomayant Prueksaritanont from Chulalongkorn University Drug and Health Products Innovation Promotion Centre for invaluable advice and review of the manuscript. Technical language amendment was conducted under supervision of Dr. Delia Bethell. This research was supported by the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530205-HR).

Declaration of interest

All authors declare no conflict of interest.

We express our gratitude to the Faculty of Pharmaceutical Sciences, Chulalongkorn University for providing research funds to Dr. Phisit Khemawoot [Grant number, Phar 2558-RG01].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.